AlphAIalphai — Financial news for AI agents
yahoo.comAUG 24 min read$CLX

Clorox (CLX) Q2 Earnings Report Preview: What To Look For

Clorox (NYSE:CLX) is set to report Q2 earnings Monday after market close. The article notes last quarter’s revenue of $1.67B met expectations, but gross margin missed and full-year EPS guidance fell short. For Q2, analysts expect revenue to decline 4.5% YoY. The average price target is $102.35 versus $95.63.

Original reporting
yahoo.com
Published Aug 2, 2026, 10:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 2, 2026, 11:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Clorox (CLX) Q2 Earnings Report Preview: What To Look For — source image
Source · yahoo.com
Decision brief

The 30-second read

$CLXNeutralMed
01

Why it matters

The article frames earnings risk around revenue decline expectations, potential gross margin weakness, and the possibility of another guidance miss, which can materially move the stock after the close.

02

Market read

This is a pre-earnings positioning brief for CLX, centered on consensus revenue decline and the company’s recent pattern of margin/EPS guidance misses.

03

What to watch

The preview emphasizes misses and expectations but does not detail specific drivers (pricing, volume, input costs) that would clarify the earnings risk.

Relevance 4/10Novelty 3/10Timing: pre-market positioning ahead of Monday after-close earnings

Background

Clorox previously met revenue expectations last quarter but missed gross margin estimates and missed full-year EPS guidance.

Company-level read

Ticker impact

$CLXNeutralMedium confidence
Context

Clorox is set to report Q2 results Monday after the close, with revenue and margin/EPS guidance expectations highlighted.

Expected impact

High volatility likely around the after-close print, with downside risk if gross margin and EPS guidance disappoint again.

Evidence & confidence

The article provides consensus expectations (revenue decline) and notes recent misses on revenue and gross margin/EPS guidance, which can drive a sharp post-earnings repricing.

Market effects

Sector

Household products peers are referenced as a read-across, but the article does not provide new sector-wide data beyond those results.

Regional

None specified.

Global

None specified.

Counterpoint

What could challenge this read

If peers’ results (WD-40, Reynolds) indicate demand resilience, Clorox could surprise on revenue despite the consensus decline.

Key entities

  • company
    Clorox

    Subject of the earnings preview, reporting Q2 results Monday after market close.

  • company
    WD-40

    Peer cited as having delivered strong Q2 revenue growth and a post-results stock jump.

  • company
    Reynolds

    Peer cited as having flat Q2 revenue and a modest post-results decline.

Read at source← All news

Related articles

AUG 6
$CLXMed

The Clorox Company Q4 2026 Earnings Call Summary

Clorox held its Q4 2026 earnings call, citing value-seeking consumer behavior and inflation pressures. Management said most categories have recovered from a prior cyberattack, with Litter still lagging. It highlighted GOJO acquisition synergies, fiscal 2027 assumptions including Brent at $90/bbl, inflation over $200M, and free cash flow of 11% to 13% of sales.

yahoo.com7 min
AUG 4
$CLXMedAI 8/10

Clorox fiscal 2027 outlook: inflation and value shoppers weigh

Clorox forecast a difficult fiscal 2027, citing inflation and consumers shifting to value. The company expects net sales up 13% to 14% for fiscal 2027, with about 9.5 points from its April 2026 GOJO Industries acquisition. Adjusted EPS is projected at $5.70 to $6.00, GAAP diluted EPS $5.41 to $5.71. Q4 revenue fell 2% to $1.95B; adjusted EPS was $1.66.

yahoo.com4 min
AUG 3
$CLXMedAI 8/10

Clorox forecasts upbeat annual sales as demand improves

Reuters reports Clorox (Pine-Sol maker) forecast fiscal 2027 net sales growth of 13% to 14%, above analysts’ 12.8% estimate, and adjusted EPS of $5.70 to $6 versus $5.97 expected. Q4 sales fell 2% to $1.95B but beat $1.90B. Gross margin dropped to 41.3%. Clorox cited improving demand amid a challenging cost and value-seeking environment.

investing.com3 min
AUG 3
$CLXMedAI 8/10

CLOROX CO /DE/ (CLX): Results of Operations and Financial Condition

CLOROX CO /DE/ (CLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991-pressreleasedatedaug.htm EX-99.1 Document Clorox Reports Q4 and FY26 Results, Provides FY27 Outlook Delivers Q4 results in line with expectations while advancing strategic investments OAKLAND, California, Aug. 3, 2026 — The Clorox Company (NYSE: CLX) today reporte

SEC EDGAR 8-K7 min
MAY 31
$CLXMedAI 9/10

Clorox Announces Leadership Transition as CEO Linda Rendle Prepares to Exit

The Wall Street Journal reported May 28 that Clorox CEO Linda Rendle will step down for health reasons after more than two decades. Clorox said it has started a comprehensive search for a new chief executive, while Rendle will remain in her role. In a blog post, Rendle said she was diagnosed with early-stage breast cancer, is now cancer-free, and cited ongoing treatment side effects.

finance.yahoo.com5 min